The effect of decitabine (DAC) treatment on glioma cells
The objective of this study is to identify molecular determinants of DAC response in gliomas Overall design: Two biological replicates were analyzed for each of 6 conditions (four cell lines; DMSO or DAC treatment per each cell line)